Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
AIMS: In this study, we sought to determine the role of ecto-nucleotidases and adenosine receptors in calcific aortic valve disease (CAVD). The expression of ecto-nucleotidases, which modify the levels of extracellular nucleotides/nucleosides, may control the mineralization of valve interstitial cells (VICs). We hypothesized that expression of ectonucleotide pyrophosphatase/phosphodiesterase 1 (NPP1), which generates AMP, and 5'-nucleotidase (CD73), an enzyme using AMP as a substrate to produce adenosine, may co-regulate the mineralization of the aortic valve. METHODS AND RESULTS: We have investigated the expression of NPP1 and 5'-nucleotidase in CAVD tissues and determined the role of these ecto-nucleotidases on the mineralization of isolated VICs. In CAVD tissues (stenotic and sclerotic), we documented that NPP1 and 5'-nucleotidase were overexpressed by VICs. In isolated VICs, we found that mineralization induced by adenosine triphosphate was decreased by silencing NPP1 and 5'-nucleotidase, suggesting a role for adenosine. Adenosine and specific A2a adenosine receptor (A2aR) agonist increased the mineralization of VICs. Silencing of A2aR in human VICs and the use of A2aR(-/-) mouse VICs confirmed that A2aR promotes the mineralization of cells. Also, A2aR-mediated mineralization was negated by the transfection of a mutant dominant-negative Gαs vector. Through several lines of evidence, we next documented that adenosine stimulated the mineralization of VICs through a cAMP/protein kinase A (PKA)/cAMP response element-binding protein (CREB) pathway, and found that CREB positively regulated the expression of NPP1 in a positive feedback loop by physically interacting with the promoter. CONCLUSION: Expression of NPP1 and 5'-nucleotidase by VICs promotes the mineralization of the aortic valve through A2aR and a cAMP/PKA/CREB pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several ectonucleotidases such as ALP, ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) and 5′-nucleotidase (5′-NT, also called CD73) are overexpressed in human stenotic aortic valves”
From Calcific aortic stenosis (2016) · cites this paper as [111]
In the citing paper
“the over activity of E-NPP 1 and 5′-NT in human stenotic aortic valves depletes extracellular ATP and produces adenosine111.”
From Calcific aortic stenosis (2016) · cites this paper as [111]
Citations
Cites
Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL
Heinemeyer, T. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.362 · Cited by 1,451
Yegutkin, G. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.024 · Cited by 1,154 · cited 1×
“Also, it is possible that, by producing AMP, NPP1 modulates the signalling through adenosine receptors.(10) To this effect, 5′-nucleotidase (CD73) is using AMP as a substrate to produce adenosine, which could exert a control over the mineralization of the aortic valve.”
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030 · cited 2×
“Therefore, in conditions where NPP1 and 5′-nucleotidase are co-expressed and up-regulated, it is likely that adenosine will be produced and therefore will modulate the function of adenosine receptors.(22) We found that HVICs expressed a high level of NPP1 and 5′-nucleotidase.”
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Self-citationThe Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology
Liu, A. C., Joag, V. R., & Gotlieb, A. I. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070251 · Cited by 632
NT5E Mutations and Arterial Calcifications
St. Hilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., Carlson-Donohoe, H., Lederman, R. J., Chen, M. Y., Yang, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0912923 · Cited by 455
Okawa, A., Nakamura, I., Goto, S., Moriya, H., Nakamura, Y., & Ikegawa, S. (1998) · Nature Genetics · doi:10.1038/956 · Cited by 422 · cited 1×
“PPi is a strong inhibitor of mineralization and NPP1 knockout mice develop ectopic mineralization of tendons.(5) On the other hand, overexpression of NPP1 in VICs and chrondrocytes”
Messika-Zeitoun, D., Aubry, M.-C., Detaint, D., Bielak, L. F., Peyser, P. A., Sheedy, P. F., Turner, S. T., Breen, J. F., Scott, C., Tajik, A. J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000135469.82545.d0 · Cited by 386
Caira, F. C., Stock, S. R., Gleason, T. G., McGee, E. C., Huang, J., Bonow, R. O., Spelsberg, T. C., McCarthy, P. M., Rahimtoola, S. H., & Rajamannan, N. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.040 · Cited by 371
Goding, J. W., Grobben, B., & Slegers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00058-9 · Cited by 364 · cited 6×
“Accordingly, a recent report has also documented that porcine VICs express 5′-nucleotidase.23 Transforming growth factor-b1, a growth factor suspected to play a role in CAVD, is also a positive regulator of NPP1.”
Influential
Cited by
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Self-citationCalcific aortic valve disease: mechanisms, prevention and treatment
Moncla, L.-H. M., Briend, M., Bossé, Y., & Mathieu, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00845-7 · Cited by 306
Self-citationHadji, F., Boulanger, M.-C., Guay, S.-P., Gaudreault, N., Amellah, S., Mkannez, G., Bouchareb, R., Marchand, J. T., Nsaibia, M. J., Guauque-Olarte, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023116 · Cited by 223
Self-citationMedical Treatment of Aortic Stenosis
Marquis-Gravel, G., Redfors, B., Leon, M. B., & Généreux, P. (2016) · Circulation · doi:10.1161/circulationaha.116.023997 · Cited by 162
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Greenberg, H. Z. E., Zhao, G., Shah, A. M., & Zhang, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab142 · Cited by 123
Metadata
- Authors
- Mahmut, A., Boulanger, M.-C., Bouchareb, R., Hadji, F., & Mathieu, P.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Mathieu, Patrick
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-02-02
- Volume
- 106
- Issue
- 1
- Pages
- 109-120
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W1995437010
- Cited by
- 48
- References
- 41
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 9 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 1
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval (MOP114893, MOP245048)
- Canadian Institutes of Health Research (MOP114893, MOP-245048)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Keywords
- calcific aortic valve disease, ectonucleotidases, adenosine, adenosine A2A receptor, NPP1, CD73, 5'-nucleotidase, valvular interstitial cells, calcification, cAMP/PKA/CREB pathway, extracellular nucleotides
- MeSH terms
- Bicuspid Aortic Valve Disease, Adenosine, Cyclic AMP, Adenosine Triphosphatases, Aged, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Disease Models, Animal, Female, Heart Defects, Congenital, Heart Valve Diseases, Humans, Male, Middle Aged, Phosphoric Diester Hydrolases, Pyrophosphatases, Signal Transduction, 5'-Nucleotidase, Cyclic AMP Response Element-Binding Protein, Cyclic AMP-Dependent Protein Kinases, Mice, Knockout, Receptor, Adenosine A2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor. https://app.cochat.ai/papers/10.1093/cvr/cvv027
- The paper
- Mahmut, A., Boulanger, M.-C., Bouchareb, R., Hadji, F., & Mathieu, P. (2015). Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor. Cardiovascular Research. https://doi.org/10.1093/cvr/cvv027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.